Consistent with this hypothesis was the observation that subjects with lysine-to-glutamate mutation within the receptor binding domain, at residue 146, of apoE, displayed a dominant dysbetalipoproteinemia phenotype with an early age onset [37]. Here, APOE is linked to hyperlipoproteinemia type 3.